27
Oct
2025
Report from China: Setting Sight on New Modalities and Global Markets
Chinese biotechs opened 2025 with a bang at JPM week, and the momentum has continued. Much of the conversation early this year was about how the US could rise to the challenge, and hold onto its historic position as the world leader in biotech innovation (see my Jan. 8, 2025 editorial in TR). The evidence of a China biotech renaissance... Read More